OXiGENEInc preclinical data

OXGN (New York) said the number of vomiting incidents was lowered in a 15-dog, cross-over study using cisplatin as the emetic, but the data did not achieve statistical significance (p=0.06 compared to standard anti-emetics).

The dose of Neu-Sensamide was not necessarily optimal, and further studies are underway, said Ronald Pero, chief scientist and president. Overall anti-emetic properties were comparable to both metoclopramide and Ondansetron. ...